Skip to main content

Table 7 Derivates of terpenes potentially act as antiviral agents

From: Recent progress on drugs discovery study for treatment of COVID-19: repurposing existing drugs and current natural bioactive molecules

Compound/Extract

Plant sources

Antiviral activities

Assays

Activity*

Refs.

Black seed oil (BSO) or habatussaudah

Nigella sativa

Murine cytomegalo virus

In vivo using a viral plaque-forming assay of BALB/c mice spleen and liver

Undetected virus at the ratio of the effector to target cells was 20:1

[99]

Manuka oil

 

HSV

In vitro using a plaque reduction assay on RC-37 cells (monkey kidney cells)

IC50 = 0.96 mg/mL

[318]

Laurus nobilis oil containing β-ocimene, 1,8-cineole, α-pinene, β-pinene

Laurus nobilis

SARS-CoV (isolate FFM-1 from Germany)

In vitro using visually scoring of the virus-induced cytopathogenic effect (CPE) for 48 h post-infection on Vero cells

IC50:120 mg/mL; SI of 4.16

[101]

Ethyl acetate and methanol extracts of aerial parts of D. virgatus

Daucus virgatus (Poir.) Maire

Coxsackievirus B (CV-B)

In vitro using plaque reduction assay on Hep-2 cell line

IC50 ethylacetate and methanol extracts = 98.16 and 60.08 mg/mL

[319]

Ethanol extracts

Mentha piperita

Desmodium canadense

Thymus vulgaris

Avian infectious bronchitis virus (IBV)

In vitro using plaque reduction assay on Vero cells

TCID = 1.83 ± 0.31–3.45 ± 0.21 log10

EC50 = 0.003–0.076 mg

[320]

Betulinic acid

 

SARS-CoV 3CL pro

In vitro using FRET method

IC50 10 mM

[95]

The fraction containing high of cannabidiol (FCBD)

Cannabis sativa strain Arbel

Interleukin: IL-6 dan IL-8

In vitro using enzyme-link immunosorbent assay on A549 cells

IC50 of 3.45 and 3.49 mg/mL

[311]

Artemisinin content

Artemisia annua L. (dried leaves)

SARS-CoV-2 USA/WA1

In vitro using cytophatic effect assay on Vero E6 cells infected by SARS-CoV-2

IC50 of 0.01–0.14 mg

[313]

Cryptotanshinone

Salvia miltiorrhiza

SARS-CoV PLpro

In vitro using proteolysis of the fluorogenic substrate

IC50 = 0.8 ± 0.2 μM

[321]

Dihydrotanshinone I

Salvia miltiorrhiza

SARS-CoV Mpro

In vitro using proteolysis of the fluorogenic substrate

IC50 = 14.4 ± 0.7 μM

[321]

Pachymic acid

Dried sclerotia of Poria cocos (Schw.). Wolf

SARS-CoV-2 Mpro recombinant

In vitro using the fluorogenic substrate for inhibition assay

IC50: 18.607 μM

[312]

Garlic essential oil containing 17 organosulfurs

 

ACE2 protein and main protease of SARS-CoV-2

In silico using MOE 2015.10 on ACE2 protein and 6LU7 (Mpro)

ACE2:

diallyl tetrasulfide and allyl disulfide − 14.06 and − 12.84 kcal/mol

Mpro:

Allyl disulfide and allyl trisulfide − 15.32 and − 15.02 kcal/mol

[322]

β-farnesene

α-farnesene

farnesol

α-bulnesene

 

SARS-CoV-2: Mpro (main protease), Nsp15/NendoU (endoribonucleoase), ADRP (ADP-ribose-1′′-phosphatase), rS (binding domain of the SARS-CoV-2 spike protein), RdRp (RNA-dependent RNA polymerase), and hACE2 (human angiotensin-converting enzyme)

In silico using Molegro Virtual Docker v. 6.0.1 on SARS-CoV-2 Mpro (5R7Z, 5R80, 5R81, 5R82, 5R83, 5R84, 6LU7, 6M03, 6Y84), Nsp15/NendoU (6VWW, 6W01, 6W02), rS (6M0J, 6M17, 6VX1, 6VW1), RdRp (6M71)

Docking Score (DS)

SARS-CoV-2 Mpro = (E)-β-farnesene − 115.4 kJ/mol

SARS-CoV Nsp15/NendoU = (E,E)-alpha-farnesene -107.5 kJ/mol

SARS-CoV-2 ADRP = (E)-β-farnesene -116.3 kJ/mol

SARS-CoV-2 RdRp = (E,E)-farnesol -89.6 kJ/mol

hACE2 = alpha-bulnesene < -100 kJ/mol

[207]

Eucalyptol (1,8-cineole) in eucalyptus oil

 

MPro/3CLpro of SARS-CoV-2

In silico using 1-click dock and swiss dock tools

DS = − 4.2

ΔG = − 6.04 kcal/mol

[323]

Jensenone in eucalyptus oil

 

MPro/3CLpro of SARS-CoV-2

In silico using 1-click dock and swiss dock tools

DS = − 5.5

ΔG = − 6.03 kcal/mol

[205]

Cuminal

Carvacrol

Myrtanol

Pinocarveol

 

Receptor binding domain (RBD) of the S1 glycoprotein (residues 319–541)

In silico using AutoDock Vina on RBD of SARS-CoV-2 S1 subunit (6M07)

Binding affinity (kcal/mol):

Cuminal − 4.9

Carvacrol − 4.9

Myrtanol − 5.3

Pinocarveol -5.0

[324]

Lauruside 5

Laurus nobilis

SARS-CoV-2

In silico using 1-Click Mcule on SARS-CoV-2 Mpro (6YB4)

Binding energy − 8.2 kcal/mol

[325]

Tanshinone I

 

SARS-CoV PLpro

In silico using Gold software with PLpro (6WX4)

IC50 of 8.8 mM

[92]

3-β-O-(α-L-rhamnopyranosyl-(1- > 2)α-L-arabinopyranosyl)olean-12-ene-28-O-(α-L-rhamnopyranosyl-(1- > 4)-β-D-glucopyranosyl-(1- > 6)-β-D-glucopyranosyl)ester

 

SARS-CoV-2 S-RBD

In silico using Autodock Vina with ligand 6LZG

IC50 of − 11 kcal/mol

[316]

Limonin and scopadulcic acid B

Dictamus dasycarpus, and Citrus orange

SARS-CoV-2 RdRp (6M71), hACE2 (6M1D), and Spike glycoprotein (2GHV)

In silico using Autodock 4.2

The docking score of limonin against RdRp, hACE2, and spike protein is − 9.0, − 8.9, and − 8.4. While docking score of scopadulcic acid B is − 8.6, − 8.2, and − 8.8

[192]

Carvacrol, anethol, cinnamyl acetate

 

SARS-CoV-2 RBD S1 subunit of S glycoprotein (6M0J)

In silico using AutoDock Vina

Binding affinities of three of them were − 5.2. kcal/mol

[326]

Coagulin N

Withania coagulans (Stocks) Dunal

SARS-CoV-2 spike protein (6M0J)

In silico using AutoDock Vina

Binding energy: − 9.1 kcal/mol

[164]

Glycyrrhizic acid

Glycyrrhiza glabra L. (liquorice roots)

SARS-CoV-2 TMPRSS2 (sequence NP_001128571.1)

In silico using AutoDock Vina

Binding energy: − 9.5 kcal/mol

[164]

Glycyrrhizin

Glycyrrhiza glabra L

SARS-CoV-2 spike RBD (6M0J)

In silico using AutoDock 4.2

Binding affinity: − 9.47 kcal/mol

[175]

Ashwagandhanolide, withacoagin, withaferin, and withanone

Ayurveda botanical: Withania somnifera (roots)

SARS-CoV-2 Mpro (5R84)

In silico using AutoDock 4.2.6

Docking score: − 9.9, and three other withanolide are − 8.8

[236]

Ashwagandhanolide, withacoagin, 27-hydroxywithanone

Ayurveda botanical: Withania somnifera (roots)

SARS-CoV-2 RBD spike glycoprotein (6M17)

In silico using AutoDock 4.2.6

Docking score: − 10, and two others are − 7.6

[236]

Ashwagandhanolide, muzanzagenin

Ayurveda botanical: Withania somnifera (roots)

SARS-CoV-2 RdRp (6M71)

In silico using AutoDock 4.2.6

Docking score: − 10.2 and − 9.3

[236]

Arjunic acid, theasapogenol B, euscaphic acid

Terminalia arjuna

Camelia sasanqua

Folium eriobortryde and Geum japonicum

SARS-CoV-2 Mpro (6LU7)

In silico using Autodock Vina

Binding affinities and inhibition constants:

− 8.1 kcal/mol and 1.16 μM − 8.1 kcal/mol and 1.16 μM

− 8.0 kcal/mol and 1.37 μM

[193]

Crocin, digitoxigenin, β-eudesmol,

Crocus sativus L

Nerium oleander

Lauris nobilis L

SARS-CoV-2 Mpro (6LU7)

In silico using Autodock 1.5.4

Binding energies: − 8.2, − 7.2, − 7.1 kcal/mol

[327]

Calendulaglycoside A

Calendula officinalis L

SARS-CoV-2 Mpro (6LU7)

In silico using MOE 2019 Suite

Binding-free energy: − 72.14 ± 38.78 kJ/mol

[174]

  1. *IC50 (mg/mL and mM): the concentration of particular compound or drug in inhibiting the biological process to half of the maximum. Docking score (kcal/mol): a computational result for particular program and energy to allow in predicting binding free energy and binding affinity, or ranking the complex of ligand and receptor according to specific parameters. Binding affinity (kcal/mol): an expression of the degree of ligand binding with the protein in complex formation. Binding energy (kcal/mol): the energy released due to the bond formation or the interaction of the ligand and protein which is calculated as a sum of all the intermolecular interactions presented in the complex